Clinigen Group plc (CLIN) - Pharmaceuticals & Healthcare - Dea...Clinigen Group plc (Clinigen Group) is a specialty pharmaceutical company. It carries out the manufacture and supply of small molecules and biologic drugs for clinical trials in various therapeutic areas. The company's drugs are used in various ... TransWorldNews, 1 week ago |
See all (4) images for "clinigene" | ||||
Theravance Inks Deal for VibativTheravance Inc. (THRX) recently entered into an agreement with UK-based Clinigen Group plc for the commercialization of Vibativ (telavancin) in the EU and several other European countries including Switzerland and Norway. As per the terms of the ... Yahoo! Finance, 2 months ago
Theravance Inks Deal for Vibativ - Analyst Blog
Nasdaq, 2 months ago
|
Clinigen Group acquires oncology support product from NovartisAIM-listed pharmaceutical products and services business Clinigen Group has acquired Cardioxane (dexrazoxane) from Novartis for 33m dollars in cash, payable in two tranches. Under the terms of the agreement, Clinigen will assume responsibility for ... London South East, 1 month ago
|
Clinigen Group Coverage Initiated by Analysts at Investec. (CLIN)Investment analysts at Investec assumed coverage on shares of Clinigen Group (LON: CLIN) Shares of Clinigen Group (LON: CLIN) traded up 2.52% during mid-day trading on Wednesday, hitting GBX 285.00. Clinigen Group has a one year low of GBX 195.00 ... American Banking News, 2 weeks ago
Clinigen Group plc
Hargreaves Lansdown, 1 month ago
Clinigen Group PT Raised to $5.18 (CLIN)
American Banking News, 1 month ago
Investment Analysts New Coverage for May, 1st (AGR, BRK.A, BXE, CLIN, FRGI, POT, PPO, ROSE, RUK, SDLP)
American Banking News, 2 weeks ago
|
AMRI Exec Discusses 'New Bar' in FDA EnforcementRelated tags: Vermont manufacturing, FDA, warning letter, Form 483, contract manufacturing, AMRI Related topics: Clinical Development, Contract Manufacturing, Regulatory affairs Related news: Following the completion of remediation efforts to deal ... Outsourcing Pharma, 2 weeks ago
|
Director Deals - Clinigen Group (CLIN)John Hartup, Non Executive Director, sold 500,000 shares in the company on the 1st May 2013 at a price of 265.00p. The Director now holds 33,934 shares. Story provided by StockMarketWire.com Director deals data provided MoneyAM, 2 weeks ago
|
Investec starts buy on Clinigen Group, target 290pStory provided by StockMarketWire.com Powered by IST's 2013 MoneyAM Register now for FREE Share Prices, Stock Quotes, Charts, Bulletin Boards, Indices, Watchlists, Portfolio, Market News, Research or see our Premium Services including Level 2, ... MoneyAM, 2 weeks ago
FLASH: Investec starts buy on Clinigen Group, target 290p
Stock Market Wire, 2 weeks ago
|
Clinigen agrees a new 20m b...Clinigen Group PLC Ord 0.1P (CLIN) Clinigen Group has agreed a new £20m banking facility which replaces its previous £10m facility. This new banking facility is for a period of 2 years and 3 months, maturing on 31 August 2015. The facility ... TrustNet, 2 weeks ago
Clinigen secures £20m facility for growth
Insider Media Limited, 2 weeks ago
FLASH: Clinigen agrees a new £20m banking facility
Stock Market Wire, 2 weeks ago
Clinigen agrees a new £20m banking facility
MoneyAM, 2 weeks ago
More from: , Interactive Investor...and 1 other sources
|
New ?20m banking facilityClinigen Group plc agrees a new 20 million banking facility Burton-on-Trent, UK - 29 April 2013 Clinigen Group plc ("Clinigen" or the "Group") (AIM: CLIN) has agreed a new 20m banking facility which replaces its previous 10 million facility. This ... TrustNet, 2 weeks ago
Clinigen Group plc New £20m banking facility
ADVFN UK, 2 weeks ago
|
Competition from the East is a major challenge to the aviation industry say speakersThe environment and competition from the East were the key challenges identified for the future of aviation on both sides of the pond, by speakers at an American/UK business conference. Paul Kehoe, chief executive of Birmingham Airport spoke at ... MidlandsBusinessNews.co.uk, 2 days ago
|